53484-18-7Relevant articles and documents
Synthesis and antiprotozoal activity of nitazoxanide-N-methylbenzimidazole hybrids
Soria-Arteche, Olivia,Hernandez-Campos, Alicia,Yepez-Mulia, Lilian,Trejo-Soto, Pedro Josue,Hernandez-Luis, Francisco,Gres-Molina, Jorge,Maldonado, Luis A.,Castillo, Rafael
, p. 6838 - 6841 (2014/01/06)
A series of a novel hybrid compounds between nitazoxanide and N-methylbenzimidazole were synthesized starting from the corresponding N-methyl-2-nitroanilines. The new hybrid compounds (1-13) were evaluated in vitro against Giardia intestinalis, Entamoeba
Development of a scalable synthesis of a nonbasic inhibitor of the serine protease tryptase
Dener, Jeffrey M.,O'Bryan, Colin,Yee, Robert,Shelton, Emma J.,Sperandio, David,Mahajan, Tania,Palmer, James T.,Spencer, Jeffrey R.,Tong, Zhiwei
, p. 4591 - 4595 (2007/10/03)
A chromatography-free process for the synthesis of a bis(benzimidazole)difluoromethane inhibitor of the serine protease tryptase is described. This synthesis features the introduction of the gem-difluoro moiety using the electrophilic fluorinating reagent N-fluoro-bis(phenylsulfonimide) as well as the stepwise introduction of both benzimidazole rings. A protocol for the destruction of reactive, process-related substances produced in the synthesis is also presented.
Neutrophil inhibitors to reduce inflammatory response
-
Page/Page column 7, (2010/02/05)
The invention provides novel compounds selected from the group consisting of: The compounds of the present invention are useful for the treatment and prevention of a variety of diseases and conditions associated with undesirable or abnormal inflammatory responses, such as ischemia-reperfusion injury. Accordingly, the invention further provides pharmaceutical compositions comprising these compounds. The invention still further provides methods of treatment or prevention for the above disorders using theses compounds or the compositions containing them.
4,5,6,7-tetrahydrobenzimidazole derivatives as 5HT3 -antagonists
-
, (2008/06/13)
4,5,6,7-Tetrahydrobenzimidazole derivatives represented by general formula (I) STR1 wherein groups represents the following: R1, R2, R3 : independently represent hydrogen atom, hydroxy group, a halogen atom, a lower alkyl